Bacterial Vaginosis Market Size

Market Size in USD Bn

CAGR8.9%

Study Period	2025-2032
Base Year of Estimation	2024
CAGR	8.9%
Market Concentration	Medium
Major Players	Symbiomix Therapeutics (Lupin Pharmaceuticals), Bayer AG, Pfizer Inc., Sanofi S.A., Teva Pharmaceutical Industries and Among Others

*Disclaimer: Major players are listed in no particular order.

*Source: Coherent Market Insights

Want to purchase customized report?
please let us know !

Bacterial Vaginosis Market Analysis

The bacterial vaginosis market is estimated to be valued at USD 3.79 billion in 2025 and is expected to reach USD 6.88 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.9% from 2025 to 2032.

The market has been witnessing positive trends over the past few years. Factors such as rising prevalence of bacterial vaginosis infections and growth in female population have been driving the adoption of bacterial vaginosis treatment and diagnostics.